miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. - Wikidata - awgldk - TriplyDB

miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.

miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.

http://www.wikidata.org/entity/Q38831791

about

TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Epigenetic Modifications to H3K9 in Renal Tubulointerstitial Cells after Unilateral Ureteric Obstruction and TGF-β1 Stimulation Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.Stem Cell-Derived, microRNA-Carrying Extracellular Vesicles: A Novel Approach to Interfering with Mesangial Cell Collagen Production in a Hyperglycaemic Setting.Reversal of Early Diabetic Nephropathy by Islet Transplantation under the Kidney Capsule in a Rat Model.Inhibiting MicroRNA-503 and MicroRNA-181d with Losartan Ameliorates Diabetic Nephropathy in KKAy Mice.MiRNA-21 mediates the antiangiogenic activity of metformin through targeting PTEN and SMAD7 expression and PI3K/AKT pathway.MicroRNAs as Master Regulators of Glomerular Function in Health and Disease.Epigenetics of kidney disease.Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis.Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype - Role of Risk Factors and Epigenetics.Dual Role of MiR-21-Mediated Signaling in HUVECs and Rat Surgical Flap under Normoxia and Hypoxia Condition.An update on diabetic kidney disease, oxidative stress and antioxidant agents miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy.The MicroRNA-21 signaling pathway is involved in prorenin receptor (PRR) -induced VEGF expression in ARPE-19 cells under a hyperglycemic condition.Inhibition of PTEN activity aggravates cisplatin-induced acute kidney injury.Non-genetic mechanisms of diabetic nephropathy.Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion.Integrative Analysis of miRNA and mRNA Expression Profiles in Calcium Oxalate Nephrolithiasis Rat Model.Syringic acid, a phenolic acid, promotes osteoblast differentiation by stimulation of Runx2 expression and targeting of Smad7 by miR-21 in mouse mesenchymal stem cells.MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.The hallmarks of mitochondrial dysfunction in chronic kidney disease.Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice.MicroRNA 21 is up-regulated in adipose tissue of obese diabetic subjects.LincRNA-p21 sponges miR-18b to promote the progression of diabetic nephropathy.MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy.Genome-wide Profiling of Urinary Extracellular Vesicle microRNAs Associated With Diabetic Nephropathy in Type 1 Diabetes.Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice MicroRNA-21-5p promotes proliferation of gastric cancer cells through targeting SMAD7 Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease Delivery Efficiency of miR-21i-CPP-SWCNT and Its Inhibitory Effect on Fibrosis of the Renal Mesangial Cells

P2860

Q28067425-78F405EE-E704-49A5-BCDD-239D01520084 Q28079163-328D369B-2825-470E-A8CE-855B901B2520 Q33734913-21A0E738-E8C9-492D-BF7F-1D972C9E3F63 Q35940910-53C26847-B925-4DD1-99A6-F2BE2875826F Q36127809-5B5D8C50-7D94-4A21-B441-4751D1128794 Q37306789-56BB7E8B-53D7-46B4-90B8-8C8E94C98B76 Q37368331-127CFB9E-9778-45AC-B013-051EA104B30D Q37661308-66FB5606-37D0-4558-9D75-67219D7446D9 Q39148575-5C540A5C-E094-4239-83C2-BA1AD7881FD8 Q39175636-E4050867-4B5E-4F54-804B-A358605E1AFB Q40105485-7F26B921-7EC9-47D5-9FA3-C70757E6E5AC Q41333737-7E716181-7DE9-4533-BFAD-37EF2F13E746 Q41660873-1F1D9D5F-4B0D-4BDE-9044-6518AA062311 Q42094755-D206179D-8658-41B5-A9E5-6728BEB46BC0 Q42140252-F3987A78-5BEF-4E51-949B-9679C799B562 Q42290908-63EE6EC0-33C3-4D63-8B6E-E44CBA272E72 Q47160630-00D5BFCE-5A2A-48B2-9174-9C9725A990EA Q47711556-BE7A178F-3AC9-415A-83E4-A057983E12CB Q47828965-3F61C867-B16F-4302-A483-7C6C3F8BD32B Q48119451-7E767346-5D4F-48C8-B97A-E1C530854776 Q48209434-0565465E-B024-43C1-844D-DADE96CFA4CC Q49626137-9FE1A2EA-EE0C-479E-A939-979DBCF42F78 Q50063239-FA75252B-6D17-45D9-B027-5FA15293471C Q50147874-219FFFED-BA50-4ADC-944B-E3CF5AB46870 Q51165884-D76BFFD6-047F-4BA4-A256-2F5F54CD276B Q54923265-F5403D37-DFD1-4CDF-AF4C-D7238A3DDC81 Q54970793-AEF6698C-226E-49D5-9CE9-6AF0EEE5DF4F Q55192943-94C33A56-11E4-4802-B0D7-618FF3950CF5 Q55207759-8DC5EF57-8A30-419C-85B5-408186B96075 Q57170561-143FD355-AD69-4DF0-8112-5EE333DC8E21 Q58777722-96AB51F8-E988-4843-AB39-50B9C451AF8A Q58795409-905C8180-425C-4044-BAB7-EB0C00A9778B Q59127337-3403C119-8B0C-4CA5-8F1A-AD8401BA3C92

P2860

miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.

http://www.wikidata.org/entity/Q38831791

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.

@en

type

label

miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.

@en

prefLabel

miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.

@en

P1433

Q38831791-7BFC3962-9549-478F-BDAC-45EA0AE1559F

P1476

Q38831791-01915302-B4F5-4314-803F-A4461E938FDF

P2093

Q38831791-06C3CCC2-EF25-43EB-A009-AE11FB0574B2

Q38831791-11F27DC2-3874-46F0-BE2E-62152C24121B

Q38831791-1AC5D9F7-4890-4526-99FE-C3179CF6E1DC

Q38831791-8C2BE2A1-B992-44D5-BD63-DA7AECE36780

Q38831791-9339ADA3-0D86-44DD-ADF0-5B222CEE9C18

Q38831791-A1A0D492-D8DA-47D5-B5EF-0760C2A32ECE

Q38831791-D23016CC-EE91-4ED4-B0AC-A11AA5B119E8

Q38831791-E792F64D-3452-4080-AA16-3EAC382E73E9

P304

Q38831791-C5D14796-C377-45BA-AFC7-1ECE285D0746

P31

Q38831791-7199D45A-27C4-4DBF-89A1-41ABBF5966ED

P356

Q38831791-D052DF7A-56DD-415E-975C-0D26384DB86B

P407

Q38831791-723A43C6-B468-44D6-AC00-2F3C2A6B6794

P433

Q38831791-BA84F3ED-438B-4B80-B6A9-F58B3EDEA61A

P478

Q38831791-20BBF019-39D3-4D6A-A7A5-93B021352556

P50

Q38831791-918A167C-5DDF-4F86-85B5-692A99F6BA6D

P577

Q38831791-14DA4F47-C160-4C77-A7DE-2D6D14407CE0

P5875

Q38831791-6A20D359-7E7A-4435-83F7-C0212E68F721

P698

Q38831791-C705871C-4728-4941-873A-CC99FD4EDBA0

P356

P1433

Clinical Science

P1476

miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7

@en

P2093

Aaron D McClelland

http://www.w3.org/2001/XMLSchema#string

Catherine E Winbanks

http://www.w3.org/2001/XMLSchema#string

Jay C Jha

http://www.w3.org/2001/XMLSchema#string

Mark E Cooper

http://www.w3.org/2001/XMLSchema#string

Michal Herman-Edelstein

http://www.w3.org/2001/XMLSchema#string

Phillip Kantharidis

http://www.w3.org/2001/XMLSchema#string

Radko Komers

http://www.w3.org/2001/XMLSchema#string

Shinji Hagiwara

http://www.w3.org/2001/XMLSchema#string

P304

1237-1249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/CS20150427

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282343814

http://www.w3.org/2001/XMLSchema#string

P698

26415649

http://www.w3.org/2001/XMLSchema#string